1. Home
  2. FCFS vs GKOS Comparison

FCFS vs GKOS Comparison

Compare FCFS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCFS
  • GKOS
  • Stock Information
  • Founded
  • FCFS 1988
  • GKOS 1998
  • Country
  • FCFS United States
  • GKOS United States
  • Employees
  • FCFS N/A
  • GKOS N/A
  • Industry
  • FCFS Other Specialty Stores
  • GKOS Medical/Dental Instruments
  • Sector
  • FCFS Consumer Discretionary
  • GKOS Health Care
  • Exchange
  • FCFS Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • FCFS 5.9B
  • GKOS 5.1B
  • IPO Year
  • FCFS 1991
  • GKOS 2015
  • Fundamental
  • Price
  • FCFS $127.91
  • GKOS $94.31
  • Analyst Decision
  • FCFS Buy
  • GKOS Strong Buy
  • Analyst Count
  • FCFS 3
  • GKOS 13
  • Target Price
  • FCFS $133.50
  • GKOS $135.15
  • AVG Volume (30 Days)
  • FCFS 290.5K
  • GKOS 914.5K
  • Earning Date
  • FCFS 07-24-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • FCFS 1.19%
  • GKOS N/A
  • EPS Growth
  • FCFS 21.73
  • GKOS N/A
  • EPS
  • FCFS 6.25
  • GKOS N/A
  • Revenue
  • FCFS $3,388,567,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • FCFS $2.67
  • GKOS $27.89
  • Revenue Next Year
  • FCFS $5.58
  • GKOS $27.57
  • P/E Ratio
  • FCFS $20.47
  • GKOS N/A
  • Revenue Growth
  • FCFS 5.06
  • GKOS 23.92
  • 52 Week Low
  • FCFS $100.24
  • GKOS $77.10
  • 52 Week High
  • FCFS $135.57
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • FCFS 50.75
  • GKOS 50.08
  • Support Level
  • FCFS $126.22
  • GKOS $93.52
  • Resistance Level
  • FCFS $128.99
  • GKOS $101.57
  • Average True Range (ATR)
  • FCFS 2.49
  • GKOS 3.33
  • MACD
  • FCFS -0.58
  • GKOS 0.40
  • Stochastic Oscillator
  • FCFS 35.91
  • GKOS 42.24

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: